Table 1.
Users of tamoxifen (n=42) | Users of aromatase inhibitors (n=65) | |
---|---|---|
Age, y | 49.5 (8.9) | 65.5 (9.4) |
Weight, kg | 65.7 (11.0) | 69.8 (13.9) |
BMI, kg/m2 | 24.7 (4.5) | 26.4 (4.9) |
Parity | 1.7 (0.9) | 1.7 (1.2) |
Nonmenopausal status | 31 (73.8%) | 0 (0%) |
Previous hysterectomy | 1 (2.4%) | 11 (16.9%) |
Diabetes | 1 (2.4%) | 7 (10.9%) |
Hypertension | 2 (4.8%) | 26 (40%) |
Dyslipidemia | 4 (9.5%) | 19 (29.2%) |
Current smoking | 8 (19.1%) | 10 (15.4%) |
Previous coronary heart disease | 0 (0%) | 3 (4.6%) |
Previous cerebrovascular disease | 0 (0%) | 2 (3.1%) |
Breast cancer stage | ||
0 | 7 (16.7%) | 2 (3.1%) |
IA | 22 (52.4%) | 33 (50.8%) |
IB | 2 (4.8%) | 4 (6.2%) |
IIA | 5 (11.9%) | 16 (24.6%) |
IIB | 3 (7.1%) | 8 (12.3%) |
IIIA | 2 (4.5%) | 1 (1.5%) |
IIIB | 0 (0%) | 1 (1.5%) |
IIIC | 1 (2.4%) | 0 (0%) |
Previous cancer treatment | ||
Breast surgery | 42 (100%) | 64 (98.5%) |
Time from surgery to inclusion, days | 107 (64) | 104 (73) |
Breast radiotherapy before inclusion | 33 (78.6%) | 57 (87.7%) |
Numbers are mean (standard deviation) or n (%).